Gay youth PrEP study finds good retention and reasonable adherence
Giving people information about HIV treatment as prevention lessens stigma and increases testing rates
New NNRTI doravirine suppresses HIV as well as efavirenz but with fewer central nervous system side-effects
Same-day start to antiretroviral treatment leads to faster HIV suppression in San Francisco
Opioid substitution therapy combined with HIV treatment saves the lives of more drug users than ART alone
Younger gay men have much lower risk of acquiring HIV than previous generations, but racial disparities persist
Half of African migrants diagnosed with HIV in France acquired HIV while living there
Next-generation maturation inhibitor BMS-955176 shows good antiviral activity in combination with atazanavir
